EXCEEDTHE SPACE PROVIDED. Alcoholic liver disease (ALD) is a major cause of liver disease and liver related morbidity/mortality in the United States. One major difficulty in devising specific therapies for ALD has been our limited understanding of the mechanism(s) for the development andprogression of this liver injury. Cytokines are low molecular weight mediators of cellular communication that are produced and released by numerouscell types such as monocytes, macrophages, and of particular relevance to liver disease, Kupffer cells. Pro-inflammatory cytokines, such as tumor necrosis factor a (TNF), and chemokines, such as interleukin-8, have been postulated to play a role in modulating many of the systemic manifestations of ALD and certain aspects of the liver injury in ALD. Many factors stimulate cytokine production, including endotoxin (lipopolysaccharide orLPS) and reactive oxygen intermediates (ROIs), both ofwhich are of direct relevance to this proposal. Endotoxin stimulates cytokine production via interaction with LPS binding protein (LBP), membranebound CD14, and ultimately the recently described LPS receptor, Toll-like receptor TLR4. TLR4then causes activation ofthe redox sensitive transcription factor, NFicB, with subsequent production of cytokines such as TNF. NFicB also has been identified as a survival factor against TNF induced apoptosis in multiple cell types Thus, NFicB not only serves as a transcription factor for several inflammatory cytokines such as TNF andTL-8, but also for several potentially protective factors such as inhibitors of apoptosis (lAPs). Inhibition of NFicB can initiate fulminant liver injury and hepatocyte apoptosis, at least in part, by allowing unregulated signaling via the TNF 'death domain'. We postulate that in ALD there is: 1)increased NFicB activation and TNF production in the major cytokine producing cell in the liver (Kupffer cell); and 2) decreased NFicBactivation and decreased 'protective signaling' in conjunction with increased TNF death signaling in the target cell (hepatocyte). In this proposal, we will use in vitro systems, in vivo animal models of ALD and ultimately will perform translational human studies to further define mechanisms of liver injury in ALD and potential pathways for intervention.
The specific aims of this proposal are to: 1) Evaluate mechanisms for increased NFicB activation and TNF production by monocyte/Kupffer cells in ALD (priming), 2) Evaluate mechanisms of increased susceptibility to TNF/cytokinehepatotoxicity in ALD (sensitization). PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA010496-09
Application #
6896228
Study Section
Alcohol and Toxicology Subcommittee 4 (ALTX)
Program Officer
Gentry, Thomas
Project Start
1996-03-01
Project End
2007-05-31
Budget Start
2005-06-01
Budget End
2007-05-31
Support Year
9
Fiscal Year
2005
Total Cost
$286,000
Indirect Cost
Name
University of Louisville
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
057588857
City
Louisville
State
KY
Country
United States
Zip Code
40292
Smart, Laura; Gobejishvili, Leila; Crittenden, Neil et al. (2013) Alcoholic Hepatitis: Steroids vs. Pentoxifylline. Curr Hepat Rep 12:59-65
Kirpich, Irina A; Feng, Wenke; Wang, Yuhua et al. (2012) The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease. Alcohol Clin Exp Res 36:835-46
Liu, Yanlong; Wang, Chunhong; Wang, Yuhua et al. (2012) Cobalt chloride decreases fibroblast growth factor-21 expression dependent on oxidative stress but not hypoxia-inducible factor in Caco-2 cells. Toxicol Appl Pharmacol 264:212-21
Gaetke, Lisa M; McClain, Craig J; Toleman, C Jean et al. (2010) Yogurt protects against growth retardation in weanling rats fed diets high in phytic acid. J Nutr Biochem 21:147-52
Kirpich, Irina A; Solovieva, Natalia V; Leikhter, Svetlana N et al. (2008) Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 42:675-82
Gobejishvili, Leila; Barve, Shirish; Joshi-Barve, Swati et al. (2008) Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 295:G718-24
Chang, Weiyuan; McClain, Craig J; Liu, Marcia C et al. (2008) Effects of 2(RS)-n-propylthiazolidine-4(R)-carboxylic acid on 4-hydroxy-2-nonenal-induced apoptotic T cell death. J Nutr Biochem 19:184-92
de Villiers, Willem J S; Song, Zhenyuan; Nasser, Munira S et al. (2007) 4-Hydroxynonenal-induced apoptosis in rat hepatic stellate cells: mechanistic approach. J Gastroenterol Hepatol 22:414-22
Cave, Matthew; Deaciuc, Ion; Mendez, Christian et al. (2007) Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem 18:184-95
Purohit, Vishnudutt; Abdelmalek, Manal F; Barve, Shirish et al. (2007) Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am J Clin Nutr 86:14-24

Showing the most recent 10 out of 40 publications